Nuclear Cardiology

Heart disease is the dominant reason of death in the western world. Each year in the U.S.A, above 500,000 men and women die due to coronary artery disease. During the last two decades, major strides have been done in the analysis and treatment of heart disease. Nuclear Cardiology is the main reason for beginning of the diagnosis of heart disease and the assessment of disease extent and the detection of outcomes in the setting of coronary artery disease. Nuclear cardiology studies use non-invasive methods to analyse myocardial blood flow, determine the pumping function of the heart as well as visualize the size and placing of a heart attack. Among the techniques of nuclear cardiology, myocardial perfusion imaging is the most commonly used. This Heart Congress scientific program has been CME and CPD certified.

  • Cardiac imaging
  • Single photon emission computed tomography (SPECT)
  • Positron emission tomography (PET)
  • Multi-gated acquisition (MUGA)
  • Medical imaging
  • Radiopharmaceuticals
  • Myocardial perfusion imaging
  • Evaluation of cardiac function with radionuclide ventriculography

Related Conference of Nuclear Cardiology

May 30-31, 2024

6th Euro Cardiology Congress

Vienna, Austria
May 30-31, 2024

39th World Congress on Heart Diseases

Vienna, Austria
June 20-21, 2024

5th European Summit on Cardiology Research

Dublin, Ireland
July 16-17, 2024

13th World Heart Congress

Paris, France
August 01-02, 2024

38th World Congress on Heart Diseases

Montreal, Canada
September 16-17, 2024

3rd Global Summit on Cardiology and Cardiac Surgery

Paris, France
October 24-25, 2024

11th International Conference on Interventional Cardiology

Zurich, Switzerland
October 30-31, 2024

7th Global Cardiovascular Research and Clinical Cardiology

Vancouver, Canada

Nuclear Cardiology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in